Korean Circ J.  2017 May;47(3):314-315. 10.4070/kcj.2017.0076.

Inflammation in Cardiovascular Disease

• Park CS

• KMID: 2385383
• DOI: http://doi.org/10.4070/kcj.2017.0076

Abstract

No abstract available.

MeSH Terms

Cardiovascular Diseases*
Inflammation*

Reference

1. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007; 49:2129–2138. PMID: 17531663.

2. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005; 45:1638–1643. PMID: 15893180.

3. Kim BJ, Cho SH, Cho KI, Kim HS, Heo JH, Cha TJ. The combined impact of neutrophil-to-lymphocyte ratio and type 2 diabetic mellitus on significant coronary artery disease and carotid artery atherosclerosis. J Cardiovasc Ultrasound. 2016; 24:115–122. PMID: 27358703.

4. Nam SH, Kang SG, Song SW. The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic Korean males: a cross-sectional study. Biomed Res Int. 2017; 2017:1989417. PMID: 28280728.

5. Cho KI, Ann SH, Singh GB, Her AY, Shin ES. Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drug-eluting stent. PLoS One. 2015; 10:e0133934. eCollection 2015. DOI: 10.1371/journal.pone.0133934. PMID: 26207383.

6. Shin HC, Jang JS, Jin HY, et al. Combined use of neutrophil to lymphocyte ratio and c-reactive protein to predict clinical outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention. Korean Circ J. 2017; 47:383–391.

7. Gislason G, Jacobsen S, Rasmussen J, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation. 2006; 113:2906–2913. PMID: 16785336.

8. Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013; 61:404–410. PMID: 23265346.

9. O'Donoghue ML, Glaser R, Cavender MA, et al. Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial. JAMA. 2016; 315:1591–1599. PMID: 27043082.